NASDAQ:COLL
Collegium Pharmaceutical Stock News
$34.25
+0.430 (+1.27%)
At Close: May 24, 2024
Citigroup Inc. Purchases 6,588 Shares of Collegium Pharmaceutical Inc (NASDAQ:COLL)
09:08am, Monday, 23'rd Mar 2020
Citigroup Inc. boosted its position in Collegium Pharmaceutical Inc (NASDAQ:COLL) by 50.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 19,663 shares
Edited Transcript of COLL earnings conference call or presentation 27-Feb-20 9:30pm GMT
05:20pm, Sunday, 22'nd Mar 2020
Q4 2019 Collegium Pharmaceutical Inc Earnings Call
Needham Reaffirms Their Buy Rating on Collegium Pharmaceutical (COLL)
12:59pm, Friday, 20'th Mar 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Collegium Pharmaceutical (COLL), with a price target of $38.00. The
Top Ranked Growth Stocks to Buy for March 20th
11:44am, Friday, 20'th Mar 2020
Top Ranked Growth Stocks to Buy for March 20th
Top Ranked Growth Stocks to Buy for March 20th
11:44am, Friday, 20'th Mar 2020
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 20th
Analysts Are Bullish on These Healthcare Stocks: Avid Bioservices (CDMO), Agile Therapeutics (AGRX)
11:16am, Friday, 20'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avid Bioservices (CDMO), Agile Therapeutics (AGRX) and
Analysts Offer Insights on Healthcare Companies: Novavax (NVAX), Marinus (MRNS) and Verrica Pharmaceuticals (VRCA)
11:08am, Tuesday, 17'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Novavax (NVAX), Marinus (MRNS) and Verrica Pharmaceuticals
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Novavax (NVAX
Charles Schwab Investment Management Inc. Lowers Stake in Collegium Pharmaceutical Inc (NASDAQ:COLL)
08:28am, Tuesday, 17'th Mar 2020
Charles Schwab Investment Management Inc. lowered its stake in shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) by 35.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 141,434
BRIEF-Collegium Pharmaceutical Files Prospectus For Sale By Assertio Therapeutics Of Up To 1 Mln Shares
10:12pm, Monday, 16'th Mar 2020
Collegium Pharmaceutical Inc:
Short Interest in Collegium Pharmaceutical Inc (NASDAQ:COLL) Rises By 17.3%
05:00am, Saturday, 14'th Mar 2020
Collegium Pharmaceutical Inc (NASDAQ:COLL) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 5,150,000 shares, an increase of 17
Needham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)
09:36pm, Friday, 13'th Mar 2020
Needham analyst Serge Belanger maintained a Hold rating on Amphastar Pharmaceuticals (AMPH) today. The company's shares closed last Monday at $14.19,
Needham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)
09:36pm, Friday, 13'th Mar 2020
Needham analyst
Serge Belanger
maintained a
Hold
rating on Amphastar Pharmaceuticals (
AMPH
–
Research Report
) today. The company’s shares closed last Monday at $14.19, close to its 52-week low o
The "Low Back Pain Clinical Trials Review: H1, 2020" report has been added to ResearchAndMarkets.com's offering.
Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL) and Homology Medicines (FIXX)
01:53pm, Friday, 13'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Collegium Pharmaceutical (COLL) and Homology Medicines
